Manceau C - Search Results

1

Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review.

Manceau C, Fromont G, Beauval JB, Barret E, Brureau L, Créhange G, Dariane C, Fiard G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G, On Behalf Of The Cc-Afu Cancerology Committee Of The Association Française d'Urologie. Manceau C, et al. Cancers (Basel). 2021 Aug 24;13(17):4251. doi: 10.3390/cancers13174251. Cancers (Basel). 2021. PMID: 34503059 Free PMC article. Review.

2

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.

Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: manceau c. World J Urol. 2020 Jul;38(7):1735-1740. doi: 10.1007/s00345-019-02973-7. Epub 2019 Oct 14. World J Urol. 2020. PMID: 31612251

3

Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.

Ploussard G, Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Loison G, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: manceau c. World J Urol. 2020 Oct;38(10):2493-2500. doi: 10.1007/s00345-019-03053-6. Epub 2019 Dec 14. World J Urol. 2020. PMID: 31838560

4

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: manceau c. J Clin Med. 2020 Jan 15;9(1):225. doi: 10.3390/jcm9010225. J Clin Med. 2020. PMID: 31952120 Free PMC article.

5

Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions.

Manceau C, Roumiguié M, Lesourd M, Beauval JB, Almeras C, Aziza R, Gautier JR, Loison G, Meyrignac O, Salin A, Tollon C, Soulié M, Malavaud B, Ploussard G. Manceau C, et al. Urol Oncol. 2020 Sep;38(9):734.e11-734.e17. doi: 10.1016/j.urolonc.2020.03.023. Epub 2020 Apr 17. Urol Oncol. 2020. PMID: 32312641

6

Abiraterone acetate in combination with prednisone in the treatment of prostate cancer: safety and efficacy.

Manceau C, Mourey L, Pouessel D, Ploussard G. Manceau C, et al. Expert Rev Anticancer Ther. 2020 Aug;20(8):629-638. doi: 10.1080/14737140.2020.1785289. Epub 2020 Jun 25. Expert Rev Anticancer Ther. 2020. PMID: 32552120 Review.

7

Immunotherapy in prostate cancer: new horizon of hurdles and hopes.

Tsaur I, Brandt MP, Juengel E, Manceau C, Ploussard G. Tsaur I, et al. Among authors: manceau c. World J Urol. 2021 May;39(5):1387-1403. doi: 10.1007/s00345-020-03497-1. Epub 2020 Oct 26. World J Urol. 2021. PMID: 33106940 Free PMC article. Review.

8

[No title available]

[No authors listed] [No authors listed] PMID: 33157700

9

[No title available]

[No authors listed] [No authors listed] PMID: 33157708

10

MRI Characteristics Accurately Predict Biochemical Recurrence after Radical Prostatectomy.

Manceau C, Beauval JB, Lesourd M, Almeras C, Aziza R, Gautier JR, Loison G, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M, Ploussard G. Manceau C, et al. J Clin Med. 2020 Nov 26;9(12):3841. doi: 10.3390/jcm9123841. J Clin Med. 2020. PMID: 33256176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page